BMO Capital Maintains Outperform on Nutrien, Lowers Price Target to $110
BMO Capital analyst Joel Jackson maintains Nutrien (NYSE:NTR) with a Outperform and lowers the price target from $115 to $110.
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
All news is property of their respective owners.
